Pricing Log in Create free account

Werewolf Therapeutics, Inc. (HOWL) vs ImageneBio, Inc. (IMA)

Werewolf Therapeutics, Inc. and ImageneBio, Inc. are both Biotechnology companies. Werewolf Therapeutics, Inc. and ImageneBio, Inc. are of similar size ($49.6M and $47.3M). Werewolf Therapeutics, Inc. grew revenue faster over the last twelve months: −5.21% against −68.0%. ImageneBio, Inc. has the higher net margin (0.00% vs −141.9%) and the lower return on invested capital (−622.4% vs 0.00%). Across the 15 metrics below, ImageneBio, Inc. leads on 8 and Werewolf Therapeutics, Inc. on 7.

Valuation

Metric HOWL IMA Biotechnology median
P/E n/m n/m 10.60
P/S 1.99 10.81 9.40
P/B 2.98 0.47 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1.98 2.71 9.02
Earnings yield (73.00%) (136.60%) (32.88%)
Free cash flow yield (61.47%) (77.70%) (23.13%)

Profitability

Metric HOWL IMA Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin (128.18%) 0.00% 0.00%
Net margin (141.94%) 0.00% 0.00%
Free cash flow margin (122.51%) 0.00% 0.00%
Return on equity (119.86%) (41.34%) (51.96%)
Return on assets (59.31%) (38.34%) (46.06%)
Return on invested capital 0.00% (622.37%) 0.00%

Growth

Metric HOWL IMA Biotechnology median
Revenue growth (TTM) (5.21%) (67.95%) 6.76%
EPS growth (last fiscal year) 18.40% 56.38% 29.88%
Revenue growth, 5-year CAGR — (38.64%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HOWL IMA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.91 21.47 4.97
Net debt to EBITDA 0.97 2.85 1.01

Dividend

Metric HOWL IMA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric HOWL IMA Biotechnology median
Market cap 49.57m 47.28m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack